Clinical significance of interleukin-1 genotype in smoking patients  as a predictor of peri-implantitis: a case-control study by García Delaney, Cristina et al.
Med Oral Patol Oral Cir Bucal. 2015 Nov 1;20 (6):e737-43.                                                                                                                                                                IL-1 genotype and peri-implantitis
e737
Journal section: Oral Surgery
Publication Types: Research
Clinical significance of interleukin-1 genotype in smoking patients 
as a predictor of peri-implantitis: A case-control study
Cristina García-Delaney 1, Maria-Ángeles Sánchez-Garcés 2, Rui Figueiredo 3,  Alba Sánchez-Torres 4, Cosme 
Gay-Escoda 5
1 DDS. Master of Oral Surgery and Orofacial Implantology. School of Dentistry of the University of Barcelona, Spain
2 MD, DDS, MS, PhD, Associate Professor of Oral Surgery. Master’s Degree Program in Oral Surgery and Implantology, School 
of Dentistry, University of Barcelona, Barcelona. Researcher of the IDIBELL Institute, Barcelona, Spain 
3 DDS, MS, PhD, Associate Professor of Oral Surgery. Master’s Degree Program in Oral Surgery and Implantology, School of 
Dentistry, University of Barcelona, Barcelona. Researcher of the IDIBELL Institute, Barcelona, Spain
4 DDS. Fellow of the Master of Oral Surgery and Orofacial Implantology. School of Dentistry of the University of Barcelona, 
Spain
5 MD, DDS, MS, PhD, Chairman and Professor of Oral and Maxillofacial Surgery, School of Dentistry, Barcelona. Director of 
the Master` s Degree Program in Oral Surgery and Implantology (EHFRE International University/FUCSO). Coordinator/Re-
searcher of the IDIBELL Institute. Head of the Oral Surgery, Implantology and Maxillofacial Surgery Department of the Teknon 
Medical Center, Barcelona, Spain
Correspondence:
Faculty of Dentistry. Campus de Bellvitge
University of Barcelona
C/ Feixa Llarga, s/n 
Pavelló Govern, 2ª planta, Despatx 2.9
08907 L’Hospitalet de Llobregat 
Barcelona Spain
rui@ruibf.com 
Received: 05/02/2015
Accepted: 21/05/2015
Abstract
Background: Interleukin-1 (IL-1) is a proinflammatory cytokine that plays an important role in the pathogenesis 
of periodontitis, and so it might be useful to detect high-risk cases of peri-implantitis. It has been reported that 
IL-1 polymorphisms and smoking habit have a synergic effect, increasing the incidence of peri-implantitis. The 
aim of the present study was to evaluate the relationship between IL-1 gene polymorphisms and peri-implantitis 
in smoking patients.
Material and Methods: A case-control study was performed in 27 patients with peri-implantitis and 27 patients 
with healthy implants. All patients included were smokers. IL-1A-C889T, IL-1B+C3953T and IL-1RN+T2018C 
were identified by polymerase chain reaction (PCR) amplification in order to establish a relation between these 
variables and the presence of peri-implantitis. A bivariate analysis was performed and odds-ratio (OR) were cal-
culated.
Results: The incidence of peri-implantitis was significantly higher in patients with previous history of periodonti-
tis (p=0.024; OR=10.9). Both groups were similar regarding IL-1A-C889T, IL-1B+C3953T and IL-1RN+T2018C 
genotypes. No increased risk in heavy smokers with IL-1 polymorphism was found.
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Conclusions: IL-1 genotypes do not seem to be good predictors of peri-implantitis in the great majority of smoking 
patients. Furthermore, no synergic effect was found between IL-1 genotypes and heavy smokers. Patients with a 
previous history of periodontitis were more prone to peri-implantitis.
Key words: Peri-implantitis, interleukin-1 genotype positive, case-control study, smoking.
Introduction 
The treatment of partial and total edentulism with im-
plant-supported prosthesis is highly predictable, with a 
low complication rate (1,2). However, peri-implant dis-
eases are frequent (56% of the subjects and 43% of the 
implants) and can eventually lead to long-term failures 
(3). A diagnosis of peri-implantitis is made when bone 
loss and bleeding on probing are observed, with or with-
out concomitant deepening of peri-implant pockets and 
the presence of purulent drainage (4).
Systemic conditions (diabetes), environmental factors 
(smoking, alcohol, poor oral hygiene), history of peri-
odontitis, rough implant surfaces and genetic traits have 
been related with peri-implantitis according to previous 
reports (5). However, the pathogenesis, the development 
and the progression of this entity varies considerably 
depending on individual factors. For this reason, the 
identification of a marker that assesses the individual 
risk to develop peri-implantitis would be of great inter-
est to clinicians.
Proinflammatory cytokines such as interleukins (IL) 
or tumor necrosis factor α (TNF α) are biochemical 
mediators that control the host response to inflamma-
tion, stimulating the production of prostaglandins (as-
sociated with bone resorption) and metalloproteinases 
(related with collagen degradation) (6). Interleukin-1 
(IL-1) might be useful to detect high-risk cases of peri-
implantitis, especially because it plays an important 
role in the pathogenesis of periodontitis, intervening 
in the processes of immunity, inflammation, tissue de-
struction and homeostasis (7). IL-1 is a stimulator of 
connective tissue catabolism, enhances the migration 
of leukocytes into the tissues and activates fibroblasts 
and immune nucleated cells that produce prostaglan-
din E2 and metalloproteinase. IL-1 is composed by 11 
genes found in section 430-kb in the DNA of the long 
arm of chromosome 2, in the 2q12-q21 region. These 
genes produce two molecules that are genetically and 
biochemically different, but have similar biological 
functions: the IL-1 alpha (IL-1A) and IL-1 beta (IL-
1B) (1,2,8). Also these genes are responsible for the 
synthesis of the antagonist receptor IL-1 (IL-1RN) (8). 
Genetic polymorphism occurs when the gene s´ structure 
is altered. Patients who are positive for allele 2 at IL-1A 
-899 and IL1B +3953 loci are described as being “geno-
type positive”. Only a small fraction of these genetic 
variations are phenotypically important, since altera-
tions in amino acid sequence are infrequent (9). Appar-
ently, genetic polymorphisms seem to have a regulatory 
effect on the secretion of these IL-1A, IL1B and IL1RN, 
increasing or decreasing the production according to 
the expressed allele. When a genetic variation occurs in 
the IL-1 (-889 locus in the IL-1A and +3953 locus in the 
IL-1B) an increased level of IL-1 is expected, therefore 
enhancing inflammatory activity. On the other hand, 
when IL-1RN is involved, the level of this substance is 
lower allowing more molecules to join the IL-1 recep-
tor, also causing inflammation (10). 
The role of these genetic polymorphisms in the etiol-
ogy and progression of peri-implant diseases is still 
unclear and needs further research, with several papers 
showing opposing results. Another interesting aspect 
that has been reported is that IL-1 polymorphisms and 
smoking habit seem to have a synergic effect, increas-
ing the incidence of peri-implantitis (11). Therefore, it 
would be interesting to perform a study to determine if 
IL-1 polymorphism is a risk factor for peri-implantitis 
and to analyze the association between IL-1 genotypes 
and the amount of tobacco consumption.
Material and Methods 
A retrospective case-control study involving 54 cau-
casian smoker patients with dental implants treated 
in 2012 in the Oral Surgery and Implantology master 
degree program of the Faculty of Dentistry, Universi-
ty of Barcelona (Spain) was performed. Patients were 
enrolled into 2 different groups (ratio 1:1) according 
to the following criteria: Peri-implantitis (PI) group 
consisted of 27 patients consecutively diagnosed with 
peri-implantitis according to the criteria described by 
Koldsland et al. (12) (bleeding on gentle probing (BoP) 
of the peri-implant tissues or suppuration and bone loss 
> 2mm); Control group (CG) included 27 patients that 
attended the dental hospital with healthy implants (no 
BoP, bone loss < 2mm, no suppuration). 
A complete periodontal examination, with probing 
depth (deepest value for each implant was registered), 
peri-implantary Mombelli plaque and bleeding index 
(PPI and PBI) (13) and suppuration was made in all cas-
es. Periapical radiographies using the long-cone parallel 
technique were made for the measurement of the bone 
loss counting the number of mm without bone support. 
A single researcher assessed the mesial and distal as-
pects of each implant, and registered the highest value. 
A second surgeon reviewed all radiographies, in order 
to confirm the diagnosis. Cases with incomplete data or 
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with doubtful diagnosis were excluded from the analy-
sis. All patients included in the study were smokers (> 3 
cigarettes/day, >5 years of habit) and healthy (ASA I or 
II). The functional loading time of the implants was of 
18 months or higher. 
Data about the surface and position of the implants 
(anterior or posterior), type of prosthesis (removable or 
fixed), history of periodontitis and tobacco consump-
tion (light smoker: <10 cigarretes/day; heavy smoker: 
≥10 cigarretes/day) was collected.
All patients were explained the nature and objectives 
of the study, and signed an informed consent prior to 
inclusion in the study. The study protocol was reviewed 
and approved by the institutional review board (Ethical 
Committee of Clinical Investigation, University of Bar-
celona Dental School; reference 06/2012). The Helsinki 
Declaration guidelines were followed throughout the 
study. The Strobe Statement guidelines (14) for case-
control studies were also taken into consideration when 
designing the current research.
- Analysis of genetic polymorphisms
Epithelial cells of the oral mucosa were obtained with 
the use of a sterile cotton swab and the tip of the spatula 
was immediately placed in snap tubes (Fig. 1). 
Fig. 1. Epithelial cells were obtained with the use of a sterile cotton 
swab.
To determine genetic predisposition to peri-implantitis, 
the IL1 Genotype commercial PCR kit (PST, Hain Lifes-
cience GmbH, Nehren, Germany) was used. The kit al-
lows the detection of the following IL1-related single 
nucleotide polymorphisms (SNPs): IL-1A-C889T, IL-
1B+C3953T and IL-1RN+T2018C. DNA was obtained 
from buccal swabs after extraction using QIAamp DNA 
Mini from QIAGEN® (Hilden, Germany). The samples 
were incubated for 10 min at 56ºC with AL Buffer plus 
proteinase K. The rest of the extraction was performed 
according to manufacturer instructions. PCR was per-
formed using BIOtaq polymerase (BIOLINE®, London, 
U.K.) with the following program: 95ºC-5min + 10x 
(95ºC-30s+58ºC-2min) + 20x (95ºC-20s+72ºC-40s) + 
70ºC-8min. Hybridization and detection was performed 
according to manufacturer instructions. 
Genetic polymorphisms can arise in homozygosity or 
heterozygosity and their sum is considered a positive 
genotype. 
The sample size was calculated using the software G 
* Power 3.0. (Heinrich-Heine-Universität, Düssel-
dorf, Germany). The following parameters were used: 
α=0.05; β=0.1; positive genotype proportion in the con-
trol group of 0.2 (according to the report by Hamdy and 
Ebrahem (15); and expected positive genotype propor-
tion in the PI group of 0.4.
- Data analysis
Data were processed with the Statistical Package for the 
Social Sciences (SPSS version 12.0; SPSS, Chicago, Ill, 
USA). Normality of scale variables was explored using 
the Kolmogorov-Smirnov test with Lilliefors correc-
tion. Parametric and nonparametric tests (Pearson chi-
square, Fisher exact tests and t-student tests) were used 
to compare the groups. The patients were also divided 
in 2 subgroups (with and without previous history of 
periodontitis) because this was considered an important 
confounding variable. An additional analysis was made 
in positive IL-1 genotypes patients, to determine possi-
ble synergism between heavy smokers (≥10cig/day) and 
IL-1 genotypes alterations in peri-implantitis. Odds ra-
tios (OR) with 95% confidence intervals (95%CI) were 
calculated for each categorical variable. The level of 
significance was set at p<0.05.
Results 
The present study included 54 patients with ages be-
tween 23 and 65 years. In the PI group (n=27), the mean 
patient age was 54.4 years (range 40 to 66), while in 
the control group (n=27) the mean age was 50.6 years 
(range 23 to 66 years). The main clinical features of the 
patients, the different surfaces and position of implants 
and the need for guided bone regeneration before or at 
the time of implant placement can be observed in ta-
ble 1. An additional analysis that divided patients into 
2 groups: positive genotype (homozygosity or heterozy-
gosity) and negative genotypes for IL-1A, IL-1B and IL-
1RN, showed no significant associations between these 
variables and the study groups.
Regarding the incidence of periodontitis, a statistical 
significant difference was found between the 2 groups, 
since 26 patients (96%) in the PI group and 19 patients 
(70%) in the control group had periodontitis. The posi-
tion of the implants (anterior or posterior), the type of 
prosthesis (partial or removable), the amount of tobacco 
consumed (<10 or ≥10 cigarettes/day) and the different 
genotypes showed no statistically significant associa-
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tion with the development of peri-implantitis (Tables 1 
and 2).
Table 3 shows the distribution of smoking status, IL-
1A, IL-1B and IL-1RN genotypes in patients with and 
without periodontitis.
Discussion 
In the Sixth European Workshop on Periodontology 
(EWP), published in 2008 (16) the only risk indicators 
for peri-implantitis with clear evidence were poor oral 
hygiene, history of periodontitis and smoking habit. On 
the other hand, genetic traits and implant surface were 
considered risk indicators with conflicting and limited 
evidence for an association with peri-implant diseases. 
The following EWP, published in 2011 (4), stated that 
peri-implantitis may be initiated and/or maintained by 
iatrogenic factors such as cement remnants, inadequate 
seating or overcountouring of restorations, implant mal-
positioning and traumatizing of the pristine bone at the 
time of implant placement.
 PI Group Control Group OR(95%CI) Bivariate (p)
Age
Mean  
(range) 
54.4  
(40-66) 
50.6  
(23-66) ---- 0.119 
Gender 
Male 9 (33%) 11 (41%) 1.4 
(0.5 - 4.2) 0.779 Female 18 (67%) 16 (59%) 
Periodontitis
Yes 26 (96%) 19 (70%) 10.9* 
(1.3 – 95) 0.024* No 1 (4%) 8 (30%) 
Smoking habit 
<10 cig/day 7 (26%) 5 (18%) 0.6 
(0.2 – 2.4) 0.377 10cig/day 20 (74%) 22 (82%) 
Prothesis 
Partial 13 (48%) 17 (63%) 
---- 0.124 Total 14 (52%) 8 (30%) 
Removable 0 (0%) 2 (7%) 
Implant position 
Anterior 1 (4%) 4 (15%) 
---- 0.370 Posterior 11 (41%) 10 (37%) 
Both 15 (55%) 13 (48%) 
Implant surface 
MTX1 0 (0%) 1 (4%) ---- ---- 
Osseospeed2 4 (15%) 1 (4%) ---- ---- 
Osseotite3 1 (4%) 1 (4%) ---- ---- 
SLA4 1 (4%) 1 (4%) ---- ---- 
TSH5 3 (11%) 7 (25%) ---- ---- 
TiUnite6 18 (66%) 16 (59%) ---- ---- 
GBR procedure 
Yes 6 (22%) 10 (37%) 2.06 
(0.62-6.81) 0.372 No 21 (78%) 17 (63%) 
 
Table 1. Main clinical features of the patients included in both study groups. The OR value for the variable smoking habit was cal-
culated dividing the patients into light smokers (<10cig/day) and heavy smokers (≥10cig/day). 1Zimmer Dental, Inc, Carlsbad, CA; 
2Astra Tech Implant System, Dentsply Implants, Mölndal, Sweden; 3BIOMET 3i, Palm Beach Gardens, FL, USA; 4Straumann AG, 
Waldenburg, Switzerland; 5Defcon, Impladent, Sentmenat, Barcelona, Spain; 6Nobel Biocare AB, Göteborg, Sweden.
Genotypes PI group Control group 
OR
(95% CI) 
Bivariate 
(p)
IL-1A 
Positive 11 (41%) 14 (52%) 1.6 
(0.53-4.6) 0.586 Normal 16 (59%) 13 (48%) 
IL-1B
Positive 10 (37%) 14 (52%) 1.8 
(0.61-5.42) 0.412 
Normal 17 (63%) 13 (48%) 
IL-1RN 
Positive 12 (45%) 9 (33%) 
0.6 
(0.2-1.88) 0.577 
Normal 15 (55%) 18 (67%) 
Table 2. Distribution IL-1A, IL-1B, IL-1RN genotypes in both groups.
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The concept that microorganisms are essential for the 
development of infections around dental implants is well 
supported in the literature. It has been suggested that 
periodontal pockets of teeth may act as a reservoir for 
microorganisms to colonize the newly inserted implants 
(17). Although bacteria may be considered the initiating 
factor of periodontal disease, other aspects like genetic 
factors may be extremely important. In fact, most au-
thors agree that the host response to bacterial challenge 
is a critical factor, especially in the progression of the 
disease (18). These 2 factors (similar bacterial profile 
and genetic predisposition) might explain why patients 
with periodontitis are at great risk of developing peri-
implant diseases (19). Other studies have shown this 
association and our report also seems to support the re-
lation between periodontitis and peri-implantitis, with 
a significant OR value (OR=10.9; 95%CI=1.3 to 95) 
(19,20).
The identification of genetic polymorphism as a risk 
indicator for peri-implant infection has been inves-
tigated in a number of clinical studies with opposing 
results. Systematic reviews made by Dereka et al. (21) 
and Huynh-Ba et al. (22) stated that there is not enough 
evidence to support or refute an association between 
specific genetic polymorphism and dental implant fail-
ure respect to peri-implantitis. Therefore, systematic 
genetic testing to assess the risk of peri-implantitis can-
not be recommended as a standard of care at this time. 
Lachmann et al. (23) seem to support this statement, 
as they failed to find an association between the IL-1 
genotype and peri-implantitis. On the other hand, a 
recent meta-analysis concluded there was evidence of 
genetic effect (composite genotype IL-1A and IL-1B) 
on risk for implant failure and peri-implantitis (2). The 
results are different from ours probably because our 
study only included smoker patients, whereas the previ-
ous meta-analysis had a more broad inclusion criteria 
regarding this variable. In our opinion, this stresses the 
need to perform additional research to evaluate if the 
influence of positive genotype varies depending on the 
presence coexisting risk factors. Hamdy and Ebrahem 
(15), in a case-control study including 50 nonsmoking 
patients, found a statistically significant difference be-
tween the groups regarding IL-1 genotype detection. 
This reinforces the idea that genetic testing might be 
useful to detect high-risk cases but only in particular 
situations. Probably, genotype detection might be es-
pecially relevant in cases without important risk fac-
tors (non-smoking patients with good oral hygiene and 
without previous history of periodontitis). The lack of 
association between IL-1 positive genotypes and peri-
implantitis in our study could be explained by the high 
prevalence of smokers (100%) and periodontitis (83%). 
According to Hamdy and Ebrahem (15), the treatment 
of peri-implantitis could have a worse prognosis in IL-1 
positive genotype patients. The clinical relevance of de-
 
No periodontitis 
(n=9) 
Periodontitis
(n=45) 
PI Control Total PI Control Total 
Smoking
status
<10 cig/day 0  (0%) 
0  
(0%) 
0  
(0%) 
7 
(26.9%) 
5  
(26.3%) 
12 
(27%) 
10 cig/day 1  (100%) 
8  
(100%) 
9 
(100%) 
19 
(73.1%) 
14  
(73.7%) 
33 
(73%) 
IL-1A 
Positive 1  (100%) 
4  
(50%) 
5  
(56%) 
10 
(38.5%) 
10  
(52.7%) 
20  
(45%) 
Normal 0 (0%) 
4 
(50%) 
4  
(44%) 
16 
(61.5%) 
9  
(47.4%) 
25 
(55%) 
IL-1 B 
Positive 1  (100%) 
4  
(50%) 
5  
(56%) 
9  
(34.6%) 
10 
(52.7%) 
19 
(42%) 
Normal 0 (0%) 
4 
(50%) 
4  
(44%) 
17 
(65.4%) 
9  
(47.4%) 
26 
(58%) 
IL-1RN 
Positive 0  (0%) 
3  
(37.5%) 
3  
(33%) 
12  
(46.2%) 
6  
(31.6%) 
18  
(40%) 
Normal 1 (100%) 
5 
(62.5%) 
6  
(67%) 
14 
(53.8%) 
13 
(68.4%) 
27 
(60%) 
 
Table 3. Distribution of smoking status, IL-1A, IL-1B and IL1RN genotypes in patients with and without periodontitis. Due 
to the small amount of patients without periodontitis in the presented sample, no statistical tests were applied.
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tecting high-risk cases resides in the introduction of a 
more strict maintenance program for patients with im-
plant-supported prosthesis. Tobacco has been reported 
as a risk factor for implant failure and bone loss around 
implants (24). A systematic review and a study made 
in our department also showed a significantly higher 
risk of developing biologic complications among smok-
ers compared with non-smokers (25,26). In a report by 
Rinke et al. (27) the data of 89 patients were collected in 
a practice-based cross-sectional study. The patient-relat-
ed global prevalence rate of peri-implantitis was 11.2%. 
However, when patients had risk factors (smoking habit 
and periodontal history) the prevalence increased dra-
matically (53.3%). Some authors (28,29) have suggested 
that smoking patients with IL-1 gene polymorphism 
might have an increased risk for peri-implant bone loss, 
since a synergic effect is expected. In these reports, a 
clear association between heavy smokers with a posi-
tive IL-1 genotype and implant complications (loss of 
implant, or peri-implantitis) was found. For this reason, 
the patients of our sample were analyzed taking into 
consideration the amount of cigarettes consumed in a 
day. However, we failed to find an increased risk of peri-
implantitis in heavy smoking patients with positive IL-1 
gene polymorphism.
 
Conclusions
Patients with a history of periodontitis are more prone 
to peri-implantitis. According to the results of the 
present study, IL-1 genotypes do not seem to be good 
parameters to assess peri-implantitis predisposition in 
the great majority of smoking patients. Furthermore, no 
increased risk of peri-implantitis was found in heavy 
smokers with IL-1 positive genotypes. 
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